http://www.newstin.com/us/AVEO_PHARMACEUTICALS Global Social News Platform Copyright © 2006 I2S a.s. Copyright © 2006 I2S a.s. http://www.newstin.com/tag/us/69798009 News source: Business Wire Dyax Corp. and AVEO Pharmaceuticals, Inc. announced today that Dyax has granted AVEO a non-exclusive license to Dyax's proprietary antibody phage display libraries for the discovery and development of... Tue, 22 Jul 2008 12:01:21 GMT http://www.newstin.com/tag/us/69798009 2008-07-22T12:01:21Z http://www.newstin.com/tag/us/69804303 7:50AM UPS reports EPS in-line, beats on revs; guides FY08 EPS in-line 59.46 : Reports Q2 (Jun) earnings of $0.85 per share, in-line with the First Call consensus of $0.85; revenues rose 6.7% year/year to $13 bln vs the $12.81... Tue, 22 Jul 2008 12:31:48 GMT http://www.newstin.com/tag/us/69804303 2008-07-22T12:31:48Z http://www.newstin.com/tag/us/61276594 AsiaNet) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. (AAH: ASX). The full 56-page report can be found at www.crystalra.com . Fri, 06 Jun 2008 06:16:32 GMT http://www.newstin.com/tag/us/61276594 2008-06-06T06:16:32Z http://www.newstin.com/tag/us/60434648 AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that they have completed enrollment in... Sun, 01 Jun 2008 08:26:22 GMT http://www.newstin.com/tag/us/60434648 2008-06-01T08:26:22Z http://www.newstin.com/tag/us/59239521 AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, tannounced that on May 13, 2008, the United States Patent and Trademark Office granted U.S. Patent No. Mon, 26 May 2008 08:25:24 GMT http://www.newstin.com/tag/us/59239521 2008-05-26T08:25:24Z http://www.newstin.com/tag/us/58994826 Aveo Pharmaceuticals has announced that the US Patent and Trademark Office has granted patent covering the company's mammalian second site suppressor screen technology for identifying small molecule and antibody targets functionally relevant to cancer cell proliferation and survival. Sat, 24 May 2008 10:27:54 GMT http://www.newstin.com/tag/us/58994826 2008-05-24T10:27:54Z http://www.newstin.com/tag/us/58672187 AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that on May 13, 2008, the United States Patent and Trademark Office granted U.S. Patent No. Thu, 22 May 2008 14:01:14 GMT http://www.newstin.com/tag/us/58672187 2008-05-22T14:01:14Z http://www.newstin.com/tag/us/58204491 MBC will host its 2008 Annual Meeting on Tuesday, May 20, 2008. The half-day event will feature a keynote address from BIDMC President and CEO Paul Levy as well as opening remarks from MBC President Robert Coughlin. The event also includes exciting panel discussions with featured speakers who... Tue, 20 May 2008 13:12:08 GMT http://www.newstin.com/tag/us/58204491 2008-05-20T13:12:08Z http://www.newstin.com/tag/us/55524639 AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the Leerink Swann Solid ... ... AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is... Fri, 02 May 2008 12:40:24 GMT http://www.newstin.com/tag/us/55524639 2008-05-02T12:40:24Z http://www.newstin.com/tag/us/55021863 Worldwide Business Research will be holding a conference entitled "PharmaBiotech IP Summit," May 28-30 at the Ritz-Carlton in Philadelphia. According to WBR, "the event balances the challenges of IP protection, enforcement and management, providing both strategic and actionable insights through... Tue, 29 Apr 2008 03:53:10 GMT http://www.newstin.com/tag/us/55021863 2008-04-29T03:53:10Z